CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis AG v. Actavis Elizabeth LLC

1:14-cv-01487

📡 5G SEP • ETSI Declared

Overview

Case Number 1:14-cv-01487
Filing Date 2014-12-16
Status Terminated
Termination Date 2017-06-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

HEC Pharm USA Inc. Operating Company

Represented By

1 Attorneys Listed

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

HEC Pharm Co. Ltd. Operating Company

Represented By

7 Attorneys Listed

Steven R Daniels

Email: sdaniels@dickinsonwright.com

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Yongjin Zhu

Email: yongjin.zhu@haynesboone.com

Michael Siem

Email: msiem@devlinlawfirm.com

James A. Shimota

Email: jim.shimota@haynesboone.com

Brian Kwok

Email: brian.kwok@haynesboone.com

Aya Cieslak-Tochigi

Email: aya.cieslak-tochigi@wolfgreenfield.com

Ezra Ventures LLC NPE (Patent Assertion Entity)

Represented By

3 Attorneys Listed

Shashank S. Upadhye

Email: shashank@ipfdalaw.com

Joseph E. Cwik

UNDELIVERABLE EMAIL 4/14/2022

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Mitsubishi Tanabe Pharma Corporation NPE (University / Research)

Represented By

4 Attorneys Listed

Nao Takada

Email: naotakada@takadalegal.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Actavis Elizabeth LLC Operating Company

Represented By

2 Attorneys Listed

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Actavis Inc. Operating Company

Represented By

5 Attorneys Listed

Thomas J. Meloro

Email: tmeloro@willkie.com

Tara L. Thieme

Email: tthieme@willkie.com

Heather M. Schneider

Email: hschneider@willkie.com

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Apotex Corp. Operating Company

Represented By

6 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Sami Sedghani

Email: ssedghani@mwe.com

Dennis D. Gregory

Email: dgregory@wsgr.com

Tung-On Kong

Email: tkong@wsgr.com

Mary Procaccio-Flowers

Email: mprocaccioflowers@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Novartis AG Operating Company

Represented By

13 Attorneys Listed

Robert W. Trenchard

Email: rtrenchard@gibsondunn.com

Paul J. Kremer

Email: pkremer@gibsondunn.com

Nao Takada

Email: naotakada@takadalegal.com

Michael A. Valek

Email: mvalek@gibsondunn.com

Jane M. Love

Email: jlove@gibsondunn.com

Caitlin R. Looby

Email: caitlin.looby@wilmerhale.com

Beatrice Hahn

UNDELIVERABLE EMAIL 12/10/18

Barish Ozdamar

Email: Barish.Ozdamar@wilmerhale.com

Andrew Blythe

Email: ablythe@gibsondunn.com

Alexander N. Harris

Email: aharris@gibsondunn.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Pharmaceuticals Corporation Operating Company

Represented By

5 Attorneys Listed

Nao Takada

Email: naotakada@takadalegal.com

Alexander N. Harris

Email: aharris@gibsondunn.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

Mitsui Sugar Co. Ltd. NPE (University / Research)

Represented By

4 Attorneys Listed

Nao Takada

Email: naotakada@takadalegal.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Counter Claimant

HEC Pharm Group Operating Company

Represented By

1 Attorneys Listed

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Interested Party

Apotex Inc. Operating Company

Represented By

6 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Sami Sedghani

Email: ssedghani@mwe.com

Dennis D. Gregory

Email: dgregory@wsgr.com

Tung-On Kong

Email: tkong@wsgr.com

Mary Procaccio-Flowers

Email: mprocaccioflowers@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP • ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

✓ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
✓ Right to demand global FRAND portfolio determination.
✓ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5604229
2-amino-1,3-propanediol compound and immunosuppressant
Filed: 1993-10-18
Issued: 1997-02-18
Expired (Term Ended) +1949d PTA
Expires: 2019-02-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1949 days) / Cellect Scrutiny — Over 1949 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

88

Dispositive

61

Granted

0

Denied

2

Pending / Review

65

Motions by Category

Procedural / Extension Motion 23 Claim Construction / Markman Filing 1 Motion to Dismiss 48 Motion for Summary Judgment (Rule 56) 10 Motion to Strike / Sanctions 3 Motion for Summary Judgment (Infringement) 3

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 253 Reply Brief, in Support of their Motions to Exclude Testimony of Dr. Chander Raman and for Summary Judgment of Infringement on U.S. Pate...
Entry #288 • 2017-04-20 Document →
Motion for Summary Judgment (Rule 56) Denied
MEMORANDUM ORDER re (209 in 1:14-cv-01487-LPS) MOTION for Summary Judgment is DENIED as moot; (216 in 1:14-cv-01487-LPS) MOTION to Preclude is DENIED as moot; (...
Entry #284 • 2017-04-17 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Letter to the Honorable Leonard P. Stark from Stamatios Stamoulis regarding Withdraw of Certain Defenses - re 209 MOTION for Summary Judgment, 208 MOTION to Pre...
Entry #282 • 2017-04-14 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
REDACTED VERSION of 213 Opening Brief in Support, of their Motion for Summary Judgment on the Issue of Improper Inventorship of U.S. Patent No. 5,604,229 by Mit...
Entry #262 • 2017-03-30 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 214 Opening Brief in Support, in Support of their Motions to Exclude Testimony of Dr. Chander Raman and for Summary Judgment of Infringement...
Entry #263 • 2017-03-30 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
[SEALED] REPLY BRIEF re 208 MOTION to Preclude Defendants' Experts' Testimony at Trial of Dr. Chander Raman and for Summary Judgment of Infringement on U.S. Pat...
Entry #253 • 2017-03-28 Document →

Docket Entries

(463 total)
Pleading / Complaint

COMPLAINT filed against Actavis Elizabeth LLC, Actavis Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1642388.) - filed by Novartis AG, Mitsui Sugar Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mas) (Entered: 12/17/2014)

Entry #1 • 2014-12-16
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mas) (Entered: 12/17/2014)

Entry #2 • 2014-12-16
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/3/14. Date of Expiration of Patent: 2/18/19.Thirty Month Stay Deadline: 3/21/2018. (mas) (Entered: 12/17/2014)

Entry #3 • 2014-12-16
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,604,229;. (mas) (Entered: 12/17/2014)

Entry #4 • 2014-12-16
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Novartis AG. (mas) (Entered: 12/17/2014)

Entry #5 • 2014-12-16
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc